IRF2 was linked to the development of various cancers like colorectal, pancreatic, and hepatocellular carcinoma (HCC), by controlling the transcription of genes such as TP53, CXCL3, Bcl-2, and Bax [3,4,5]. This evidence concerns the gene IRF2 and hepatocellular carcinoma.